By using, you agree to our terms and use of cookies to enhance your experience.

Feedback sought on intravenous insulin guidelines

By Editor
15th June 2018
Audits, Care planning

An audit to find out how newly updated guidelines for the use of variable rate intravenous insulin infusion (VRIII) are being used among trusts has been launched.

In 2014 the Joint British Diabetes Societies – Inpatient Care Group (JBDS-IP) launched the document, designed to guide non-specialist teams in the appropriate and safe use of VRIII.

The organisation compiled the guidelines because it was recognised that the use of VRIII is a tool commonly used to achieve normoglycaemia in hospital inpatients. Most acute trusts have guidelines for its use, but there was a wide variation across the country, increasing the risk of errors which can potentially lead to significant morbidity and mortality.

It was also thought that VRIII was often used when not indicated, its duration was unnecessarily prolonged and the step down to other glucose lowering medication was often not practiced safely.

The JBDC document was designed to be a practical guide to be used by any healthcare professional who manage medical in-patients with hyperglycaemia. Its main aim was to allow the VRIII to be used safely, effectively and efficiently for this specific group of inpatients.

It is divided into several sections, including the evidence base for its recommendations, the practicalities of when to use a VRIII, how it is to be set up, when it should be discontinued and how a safe transition to other medication can be achieved. Safety of the use of the VRIII is emphasised throughout.

But now the JBDC is looking to update the guidelines and wants to “gather some data as to its safety and ease of use”.

Dr Stella George, a consultant diabetes and endocrinology at the East and North Herts NHS Trust, is leading the feedback. She said: “We hope that we would then launch a revised version based on the data we gather, with a particular focus on safety.

“We are asking teams to send in five completed forms to me. They are completely anonymised and hold no patient identifiable data. Any member of the diabetes team can fill it in from diabetes specialist nurses and registrars, right through to consultants.”

Each form must be returned separately and sent to Dr George, via her email address which is, with the name of their trust and the number of the form eg East and North Herts 1; East and North Herts 2 – which will help organisers identify each separate return.

Click here to access the form.

Comments (0)

Register an account or login to comment